News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
2024-04-30 08:30:07 ET UBS analyst issues BUY recommendation for ACAD on April 30, 2024 06:00AM ET. The previous analyst recommendation was Buy. ACAD was trading at $17.1 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst rec...
-- 10 academic scholarships awarded supporting siblings of Rett syndrome patients Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it has awarded 10 academic scholarships to eligible recipients of the first Rett Sibling Scholarship. The Rett Sibling Scholarship progra...
Company to host conference call and webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. A...